Novavax, Inc.Short
Possible downside from here
Looks like there is bad news from novavax, that being that their vaccine isn't effecrive against new strains of virus.
Looks to me that post market has imthe asset pumped up on the cheap in postmarket conditions ripe to be shorted at the open.
Price at end of post market being $170
Looks to me that post market has imthe asset pumped up on the cheap in postmarket conditions ripe to be shorted at the open.
Price at end of post market being $170
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.